155 related articles for article (PubMed ID: 22095001)
1. Prediction of late (24-hour) radioactive iodine uptake using early (3-hour) uptake values in Japanese patients with Graves' disease.
Osaki Y; Sakurai K; Arihara Z; Hata M; Fukazawa H
Endocr J; 2012; 59(2):173-7. PubMed ID: 22095001
[TBL] [Abstract][Full Text] [Related]
2. Prediction of thyroidal
Zhang R; Zhang G; Wang R; Tan J; He Y; Meng Z
Oncotarget; 2017 Oct; 8(46):80934-80940. PubMed ID: 29113356
[TBL] [Abstract][Full Text] [Related]
3. Correlation of radioiodine doses for 6-hr and 24-hour iodine-131 thyroid uptake values for Graves' hyperthyroidism.
Horn-Lodewyk J
Endocr J; 2019 Dec; 66(12):1047-1052. PubMed ID: 31391354
[TBL] [Abstract][Full Text] [Related]
4. The change in 123I-uptake between 3- and 24-hours is useful in predicting early response to methimazole in patients with Graves' disease.
Gemma R; Nakamura H; Mori T; Andoh S; Suzuki Y; Yoshimi T
Endocr J; 1996 Feb; 43(1):61-6. PubMed ID: 8732453
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for early hypothyroidism following the radioactive iodine therapy in Graves' disease patients.
Hu RT; Liu DS; Li B
BMC Endocr Disord; 2020 May; 20(1):76. PubMed ID: 32471411
[TBL] [Abstract][Full Text] [Related]
6. Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease.
Ota H; Amino N; Morita S; Kobayashi K; Kubota S; Fukata S; Kamiyama N; Miyauchi A
Clin Endocrinol (Oxf); 2007 Jul; 67(1):41-5. PubMed ID: 17437515
[TBL] [Abstract][Full Text] [Related]
7. Therapy dose calculation in Graves' disease using early I-123 uptake measurements.
Vemulakonda US; Atkins FB; Ziessman HA
Clin Nucl Med; 1996 Feb; 21(2):102-5. PubMed ID: 8697676
[TBL] [Abstract][Full Text] [Related]
8. Establishment of clinical diagnosis model of Graves' disease and Hashimoto's thyroiditis.
Cui Z; Wang Z; Liu X; Cai Y; Xu X; Yang T
J Transl Med; 2019 Jan; 17(1):11. PubMed ID: 30616573
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of low-dose inorganic iodine on thyroidal radioactive iodine uptake in healthy Japanese adults.
Kunii Y; Uruno T; Mukasa K; Sekiya K; Iwaku K; Suzuki A; Sugino K; Yoshimura Noh J; Ito K
Endocr J; 2016; 63(1):21-7. PubMed ID: 26560237
[TBL] [Abstract][Full Text] [Related]
10. Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease.
Yamada T; Koizumi Y; Sato A; Hashizume K; Aizawa T; Takasu N; Nagata H
J Clin Endocrinol Metab; 1984 Apr; 58(4):676-80. PubMed ID: 6421866
[TBL] [Abstract][Full Text] [Related]
11. [Effects of iodine-containing food on 99mTc and 131I uptake in patients with Graves' disease].
He GR; Ouyang W; Liu JH; Liu WY
Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1292-4. PubMed ID: 15567783
[TBL] [Abstract][Full Text] [Related]
12. Standardized Uptake Value Using Thyroid Quantitative SPECT/CT for the Diagnosis and Evaluation of Graves' Disease: A Prospective Multicenter Study.
Dong F; Li L; Bian Y; Li G; Han X; Li M; Liu J; Xue Y; Li Y; Hu Y; Tan J
Biomed Res Int; 2019; 2019():7589853. PubMed ID: 30834273
[TBL] [Abstract][Full Text] [Related]
13. fT3:fT4 ratio in Graves' disease - correlation with TRAb level, goiter size and age of onset.
Minasyan M; Dulęba A; Smalarz A; Stręk M; Bryniarski P; Przybylik-Mazurek E; Hubalewska-Dydejczyk A
Folia Med Cracov; 2020 Sep; 60(2):15-27. PubMed ID: 33252592
[TBL] [Abstract][Full Text] [Related]
14. Re-establishment of normal radioactive iodine uptake reference range in the era of universal salt iodization in the Indian population.
Ballal S; Soundararajan R; Bal C
Indian J Med Res; 2017 Mar; 145(3):358-364. PubMed ID: 28749399
[TBL] [Abstract][Full Text] [Related]
15. Postpartum thyrotoxicosis in a patient with Graves' disease. Association with low radioactive iodine uptake.
Eckel RH; Green WL
JAMA; 1980 Apr; 243(14):1454-6. PubMed ID: 6892648
[TBL] [Abstract][Full Text] [Related]
16. Radioiodine uptake after monotherapy with potassium iodide in patients with Graves' disease.
Mikura K; Yoshimura Noh J; Watanabe N; Aida A; Yoshimura R; Kinoshita A; Suzuki A; Suzuki N; Fukushita M; Matsumoto M; Yoshihara A; Sugino K; Ito K
Endocr J; 2023 May; 70(5):541-549. PubMed ID: 36843112
[TBL] [Abstract][Full Text] [Related]
17. Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis.
Izumi Y; Hidaka Y; Tada H; Takano T; Kashiwai T; Tatsumi KI; Ichihara K; Amino N
Clin Endocrinol (Oxf); 2002 Jul; 57(1):51-8. PubMed ID: 12100069
[TBL] [Abstract][Full Text] [Related]
18. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy.
Sabri O; Zimny M; Schreckenberger M; Reinartz P; Ostwald E; Buell U
Thyroid; 1999 Dec; 9(12):1181-8. PubMed ID: 10646656
[TBL] [Abstract][Full Text] [Related]
19. Influence of Short-Term Dietary and Therapeutic Iodine Restriction on the Therapeutic Effects of Radioactive Iodine Therapy in Patients with Graves' Disease.
Nishio R; Uchida T; Suzuki L; Onose H; Goto H; Yamada E; Satoh H; Watada H
Thyroid; 2021 Mar; 31(3):439-445. PubMed ID: 32729394
[No Abstract] [Full Text] [Related]
20. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
